<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03313817</url>
  </required_header>
  <id_info>
    <org_study_id>ALR_2017_17</org_study_id>
    <nct_id>NCT03313817</nct_id>
  </id_info>
  <brief_title>Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)</brief_title>
  <acronym>I-RECANAL</acronym>
  <official_title>Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke at the
      retinal level. They share the same risk factors and common pathology. The diagnosis of a CRAO
      is clinically based on the sudden occurrence of a decrease in deep visual acuity with
      fundamentally signs of reactive ischemia.

      Small studies have highlighted the value of cerebral MRI (Magnetic Resonance Imaging) in CRAO
      with almost 25% of ischemic strokes found on diffusion sequences and the demonstration of a
      correlation between anomalies in diffusion sequence and the probability of a pathology with a
      high risk of recurrence (carotid stenosis or emboligenic cardiopathy). But there are usually
      few radiological signs that allow a direct positive diagnosis of CRAO, an etiologic diagnosis
      or a prognosis. This descriptive study will focus on CRAO at the diagnostic and
      post-treatment phases in the short and medium term, in order to (i) identify imaging
      etiologic signs of CRAO with specific sequences from a 3 Tesla MRI, (ii) identify positive
      diagnostic signs of CRAO with the same specific sequences, (iii) correlate these signs with
      the visual prognosis one month after the CRAO.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2017</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Contrast enhancement of the ophthalmic artery</measure>
    <time_frame>Baseline</time_frame>
    <description>Binary variable (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of a thrombus</measure>
    <time_frame>Baseline</time_frame>
    <description>Binary variable (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of an arterial stenosis of the supra aortic trunks</measure>
    <time_frame>Baseline</time_frame>
    <description>Binary variable (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypersignal of the ophthalmic artery in diffusion</measure>
    <time_frame>Baseline</time_frame>
    <description>Binary variable (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Restriction of the apparent diffusion coefficient (ADC) at the optic nerve level and at the papilla level</measure>
    <time_frame>Baseline</time_frame>
    <description>Binary variable (yes/no)</description>
  </primary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Retinal Artery Occlusion</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <condition>Diagnosis</condition>
  <condition>Etiology</condition>
  <condition>Prognosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Additional MRI sequences</intervention_name>
    <description>Patients will be hospitalized for suspicion of CRAO. An &quot;optimized&quot; MRI will be performed with specific sequences: 3D T1 MSDE (Motion Sensitized Driven Equilibrium) &quot;dark blood&quot;; 3D Optimized diffusion centered on the optic nerves; 3D PD T1 after injection. A consultation of ophthalmology and a control MRI will be carried out one month after the CRAO. Again, specific sequences will be added: 3D T1 MSDE (Motion Sensitized Driven Equilibrium) &quot;dark blood&quot;; 3D Optimized diffusion centered on the optic nerves; DTI (Diffusion Tensor Imaging); 3D PD T1 after injection.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients hospitalized for CRAO ≤ 48 hours.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  CRAO (onset of symptoms ≤ 48 hours)

          -  Consent to participate in the study

        Exclusion Criteria:

        - Contraindications to 3 Tesla MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Salomon, MD PhD</last_name>
    <phone>0148036431</phone>
    <phone_ext>+33</phone_ext>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Augustin Lecler, MD</last_name>
    <email>alcler@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation Ophtalmologique A. de Rothschild</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augustin Lecler, MD</last_name>
      <email>alecler@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2017</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Retinal Artery Occlusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

